News Blog

 
 
  • AHA 2019 FUEL: Udenafil Improves Exercise Capacity After Fontan Surgery In a phase 3 trial, the PDE-5 inhibitor udenafil did not improve VO2 max but did improve exercise capacity in adolescents born with a single ventricle who had undergone Fontan surgery.
  • Has the Sun Set on Sulfonylureas? Inspired by a debate at the ADA Scientific Sessions, Dr. Kasia Lipska shares her thoughts--in her first blog for Medscape Medical News--on the place of sulfonylureas in the modern endocrinologist's armamentarium.